Platelet-derived growth factor-induced alterations in vinculin and actin distribution in BALB/c-3T3 cells by Herman, B. & Pledger, W. J.
Platelet-derived Growth factor-induced Alterations 
Vinculin and Actin Distribution in BALB/c-3T3 Cells 
in 
B. HERMAN *§ and W.  J. PLEDGER *s 
Department of Anatomy and Laboratories for Cell Biology,* Department of Pharmacology,* Lineberger 
Cancer Research Center, s University of North Carolina Medical School at Chapel Hill, 
Chapel Hill, North Carolina 27514 
ABSTRACT Exposure of BALB/c-3T3 cells (clone A31) to platelet-derived growth factor (PDGF) 
results in a rapid time- and dose-dependent alteration in the distribution of vinculin and actin. 
PDGF treatment (6-50 ng/ml) causes vinculin to disappear from adhesion plaques (within 2.5 
min after PDGF exposure) and is followed by an accumulation of vinculin in punctate spots 
in the perinuclear region of the cell. This alteration in vinculin distribution is followed by a 
disruption of actin-containing stress fibers (within 5 to 10 min after PDGF exposure). Vinculin 
reappears in adhesion plaques by 60 min after PDGF addition while stress fiber staining is 
nondetectable at this time. PDGF treatment had no effect on talin, vimentin, or microtubule 
distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma 
(PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 ~tM 
insulin also had no effect on vinculin or actin distribution. Other competence-inducing factors 
(fibroblast growth factor, calcium phosphate, and choleragen) and tumor growth factor 
produced similar alterations in vinculin and actin distribution as did PDGF, though not to the 
same extent. PDGF treatment of cells for 60 min followed by exposure to EGF (0.1-30 ng/ml 
for as long as 8 h after PDGF removal), or 5% PPP resulted in the nontransient disappearance 
of vinculin staining within 10 min after EGF or PPP additions; PDGF followed by 0.1% PPP or 
10/zM insulin had no effect. Treatment of cells with low doses of PDGF (3.25 ng/ml), which 
did not affect vinculin or actin organization in cells, followed by EGF (10 ng/ml), resulted in 
the disappearance of vinculin staining in adhesion plaques, thus demonstrating the synergistic 
nature of PDGF and EGF. These data suggest that PDGF-induced competence and stimulation 
of cell growth in quiescent fibroblasts are associated with specific rapid alterations in the 
cellular organization of vinculin and actin. 
Platelet-derived growth factor (PDGF) ~ is the major mitogenic 
growth factor in serum for cells of mesenchymal origin (2, 
44), in addition to being a major chemoattractant for human 
neutrophils and monocytes (13), fibroblasts (45, 49), and 
smooth muscle cell~ (50), thereby potentially playing an im- 
portant role in wound healing, atherogenesis, and cell growth. 
The biochemical mechanisms by which PDGF regulates the 
growth of cells is not known. Recent work has shown that 
PDGF and growth factors in platelet-poor plasma (PPP) func- 
Abbreviations used in this paper." C.T. Cholera toxin; DME, Dul- 
becco's modified Eagle's medium; EGF, epidermal growth factor; 
FGF, fibroblast growth factor; PDGF, platelet-derived growth factor; 
PPP~ platelet-poor plasma; SmC, somatomedin C; TGF, tumor 
growth factor. 
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tion in a synergistic manner to control the growth of BALB/ 
c-3T3 fibroblasts in tissue culture (42). PDGF alone cannot 
initiate growth of quiescent cells; however, transient treatment 
of cells with PDGF followed by plasma results in DNA 
synthesis and cell growth (41). Further work revealed that the 
plasma requirement for the stimulation of DNA synthesis in 
BALB/c-3T3 cells can be replaced by epidermal growth factor 
(EGF) and either insulin or Somatomedin C (SmC) (36). An 
interesting finding of these studies was that only brief exposure 
to PDGF was required to prime cells for responsiveness to 
plasma, and that this sensitized state (competence) lasted long 
after removal of PDGF from cells (57). This PDGF-induced 
competent state was found to decay with a half life of 18 h, 
and could also be induced by treatment of cells with fibroblast 
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growth factor (FGF), macrophage-derived growth factor, or 
calcium phosphate (53, 57). Lastly, choleragen treatment of 
cells was found to potentiate the action of PDGF in compe- 
tence induction as well as abrogate the requirement for EGF 
in cell cycle progression (32). To date, no cellular respond, 
other than induction of DNA synthesis, has been demon- 
strated in cells following exposure to EGF which required 
prior exposure of cells to PDGF. 
The finding that only brief exposure to PDGF is required 
to induce competence suggests that rapid biochemical events 
which follow PDGF binding are important in the induction 
of competence. Shortly after binding of growth factors, a 
plethora of metabolic changes in cells has been shown to 
occur. These rapid changes include alterations in the activity 
of plasma membrane Na+/H * antiport systems (31), altera- 
tions in ion fluxes (5), mobilization of intracellular calcium 
(34), alkalinization of intracellular pH (4), and phosphoryla- 
tion of plasma membrane phospholipids (18) and growth 
factor receptors (8). The latter two observations have caused 
an intense amount of interest based on the findings that tumor 
promotors have been shown to phosphorylate specific plasma 
membrane phospholipids (22), and that growth factor recep- 
tors for PDGF and EGF share with some oncogene proteins 
a tyrosine protein kinase activity (8). Exposure of cells to 
PDGF has been found to result in the phosphorylation of 
42-, 43-, and 45-kD proteins which seem to be localized at 
the plasma membrane (10). To date, the identity of the 
proteins which are phosphorylated upon PDGF addition have 
yet to be identified. 
In addition to the rapid events which occur at the plasma 
membrane of cells following PDGF addition, subsequent 
effects on gene expression have been documented (30). A 
number of specific proteins have been identified in BALB/c- 
3T3 cells induced by PDGF addition (40); one of these 
proteins which occurs early after PDGF exposure, a 29-kD 
protein, has been localized to the nucleus (38), but its function 
is unknown. Furthermore, PDGF rapidly stimulates the 
expression ofmyc andros in quiescent BALB/c-3T3 cells (30). 
If tyrosine phosphorylation of growth factor receptors and 
cellular substrates is important for growth factor action, and 
for growth factor activity that can be modulated at the tran- 
scriptional level in the nucleus, it is important to identify the 
intracellular proteins that may mediate the passage of infor- 
mation from the plasma membrane to the nucleus. The 
findings that certain growth factor receptors and oncogene 
protein products possess tyrosine kinase activity (23, 26), in 
conjunction with the localization of oncogene products to the 
plasma membrane (and in one specific case, to adhesion 
plaques [43]), prompted us to examine whether PDGF addi- 
tion to cells would affect adhesion plaque structure. PDGF 
addition to BALB/c-3T3 cells results in a rapid and reversible 
alteration in the distribution of vinculin and actin that is very 
reminiscent of that observed in virally transformed cells (26, 
48, 50), which is thought to be mediated through tyrosine 
phosphorylation. We demonstrate that this alteration is spe- 
cific for PDGF and other competence-inducing factors and 
not for other growth factors required for progression (e.g., 
EGF and SmC), and that PDGF and EGF can exert a syner- 
gistic effect with respect to the distribution of vinculin from 
adhesion plaques, which can be related to mitogenesis in these 
cells. We also report that the loss of vinculin from adhesion 
plaque in response to EGF first requires pretreatment with 
PDGF. This finding constitutes the first description of a 
specific cellular response to EGF treatment which occurs only 
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specific cellular response to EGF treatment which occurs only 
in PDGF-induced competent BALB/c-3T3 cells, but not in 
quiescent cells. Previous portions of this work have appeared 
in abstract form (25). 
MATERIALS AND METHODS 
Cell Culture: BALB/c-3T3 cells (clone A31) were grown in Dulbecco's 
modified Eagle's medium (DME)/10% heat-inactivated calf serum/4 mM 
glutamine, supplemented with penicillin at 50 U/ml and streptomycin at 50 
#g/ml in humidified 5% CO2/95% air at 37"C. Cells were seeded at 4-5 x l05 
cells/l.76 cm 2 well on glass coverslips, and cultures were used for experiments 
4-5 d after plating. 
Preparation of Growth Factors: Highly purified PDGF was pre- 
pared from boiled extracts of outdated human platelets by a combination of 
reported procedures (24, 41, 42). The PDGF was greater than 25% pure and 
was highly mitogenic at 2- l0 ng/ml in microtiter assays with density-dependent 
inhibited BALB/c-3T3 cells as described by Pledger et al. (40). The PDGF 
preparation did not contain measurable tumor growth factor (TGF) activity as 
demonstrated by radio receptor assay. PPP was purified as previously described 
from peripheral venous blood drawn from healthy volunteers (41). EGF was 
pUrified from mouse submaxillary glands by the procedure of Savage and 
Cohen (46). FGF was a gift of Dr. Dennis Gospodarowicz (University of 
California at San Francisco), while platelet-derived ~3-TGF was a gift from Dr. 
Hal Moses (Mayo Clinic, Rochester, MN). Bovine insulin and cholera toxin 
(C.T.) were purchased from Sigma Chemical Co., St. Louis, MO. SmC was a 
gift from Dr. Judson Van Wyk. 
[3H]Thymidine (DNA Synthesis) Assay: BALB/c-3T3 cells were 
grown in Falcon 24-well tissue culture plates for 4-5 d containing 2.0 ml of 
serum-supplemented DME. Confluent quiescent cultures were transferred to 
fresh medium containing PDGF, PPP, and [3H]thymidine. After incubation 
for 36 h, the cultures were processed for autoradiography as previously described 
(41, 42). 
Immunofluorescence: After exposure of BALB/c-3T3 cells to vary- 
ing concentration of growth factors, serum, or hormones in 0.5 ml of medium 
for appropriate times, cells were processed for the demonstration of vinculin, 
talin, or actin as follows. 
Cells were fixed in 3.7% formaldehyde in phosphate-buffered saline (PBS) 
(pH 7.4), 1 mM magnesium chloride (MgCl2), and 0.1 mM calcium chloride 
(CaCl2), for 5 rain at room temperature, The coverslips containing the cells 
were rinsed three times in PBS and extracted for 3 rain at room temperature 
in 0.1% Triton X-100 containing 1 mM MgCl2 and 0.1 mM CaCI2. After 
rinsing in PBS, the coverslips were incubated in either a 1:25 dilution of rabbit 
anti-vinculin antibody, a 1:25 dilution of rabbit anti-talin antibody, or a 
combination (final dilution of 1:25) of rabbit anti-talin and guinea pig anti- 
vinculin. The antibodies directed against vinculin and talin were kindly supplied 
to us by Keith Burridge (University of North Carolina at Chapel Hill) and have 
been previously characterized with regard to their specificity (19). Coverslips 
were incubated for 30 min at 37°C, rinsed three times in PBS and incubated in 
the following second antibodies. The coverslips were incubated in fluorescein 
goat anti-rabbit lgG or fluorescein goat anti-guinea pig IgG (Flow Laboratories~ 
McLean, VA). The second antibodies also contained Rhodamine-Phalloidin 
(which binds to F-actin), obtained from Molecular Probes (Junction City, OR), 
at a concentration of 5 ul of Rhodamine-Phalloidin/100 ul second antibody: 
this allowed us to visualize the distribution ofvinculin or talin and actin in the 
same cell. When cells were stained with a mixture of rabbit anti-talin and 
guinea pig anti-vinculin, the second antibody incubation was performed using 
a mixture of fluorescein goat anti-rabbit IgG and Rhodamine-sheep anti guinea 
pig IgG which did not contain any Rhodamine-Phalloidin. The coverslips were 
incubated in second antibody for 30 min at 37°C, rinsed three times in PBS, 
and mounted onto slides in a mixture of 60% glycerol/40% PBS containing 
5% n-propyl gallate. Tubulin and vimentin were visualized after the fixation of 
cells in -20°C methanol for l0 rain with a 1:50 dilution of rabbit antitubulin 
antibody which had been raised against sea urchin vinblastine crystals (kindly 
supplied by Keigi Fujiwara at the Harvard Medical School) and a 1:5 dilution 
of mouse monoclonal antivimentin antibody purchased from LAB systems of 
Chicago, IL. Incubation conditions were as previously described except that 
cells were incubated in a 1:20 dilution of fluorescein goat anti-rabbit lgG 
(tuhulin) and Rhodamine guinea pig anti-mouse IgG (vimentin). This fixation 
procedure did not allow the visualization of actin with Rhodamine-Phalloidin. 
After mounting onto slides, photographs of the cells were taken on a Zeiss IM- 
35 inverted microscope using epi-illumination and filter sets which discriminate 
between fluorescein and Rhodamine fluorescence. Photographs were taken on 
Tri-X film and developed at an effective ASA of 1600. For each experiment, 
150-200 cells per treatment were counted and scored for the presence or 
absence of vineulin and actin staining, which were distributed in adhesion 
plaques (focal contacts) and stress fibers, respectively. 
RESULTS 
PDGF Effects on the Cytoskeleton 
Exposure of quiescent BALB/c-3T3 cells to PDOF results 
in a rapid time- and dose-dependent alteration in the distri- 
bution of vinculin and actin. In untreated cells, vinculin 
staining is concentrated in adhesion plaques near the cell edge 
or at areas of cell-cell contact (Fig. 1A), as well as being 
diffusely distributed throughout the cytoplasm. The higher 
intensity observed in the perinuelear region may be due to a 
higher concentration of vinculin or a larger accessible volume 
in this region of the cell. Actin is found disposed in stress 
fibers (Fig. 1D) which course throughout the cell or are 
concentrated around the cell periphery. These stress fibers 
can often be seen terminating in vinculin-containing adhesion 
plaques. Within 2.5 min after addition of 50 ng/ml PDGF to 
BALB/c-3T3 cells, vinculin staining is lost from adhesion 
plaques (Fig. 1 B), and assumes a more punctate distribution 
in the cytoplasm, primarily concentrated at the cell center. 
Actin organization is unaffected at this time (Fig. l E). By 60 
rain of exposure to PDGF, the vinculin staining has reap- 
peared in adhesion plaques (Fig. I C), while there is little 
staining of actin in cells at this time (Fig. 1F). This latter 
finding is in agreement with the data of Bochus and Stiles (3) 
and Mellstrrm et al. (33), who have reported that PDGF 
addition to BALB/c-3T3 cells resulted in the rapid and re- 
versible loss of microfilaments and that treatment of human 
diploid glial cells with PDGF resulted in early reorganization 
of actin microfilaments and membrane ruffling. 
To determine whether exposure of cells to PDGF specifi- 
cally caused disruption of vinculin and actin or also caused 
alterations in other cytoskeletal structures as well, we exposed 
cells to PDGF (12 ng/ml for 20 min at 37°C), fixed them, 
and processed them for the immunofluorescent detection of 
talin (adhesion plaque protein [6]), vimentin (intermediate 
filaments), or tubulin (microtubules). As can be seen in Fig. 
2, although PDGF treatment caused the disappearance of 
vinculin staining in cells (Fig. 2, A and B), talin distribution 
was unaffected (cf. Fig. 2, C and D). While the images in this 
figure were obtained using rabbit anti-talin antibody, identical 
experiments using guinea pig anti-vinculin antibodies and 
rabbit anti-talin antibodies demonstrated disruption of vin- 
culin staining with the preservation of talin adhesion plaque 
staining. These results suggest that PDGF exposure results in 
a specific disruption or removal of vinculin from adhesion 
plaques while still maintaining the adhesion plaque structure 
intact (as evidenced by the lack of effect of PDGF treatment 
on talin). Whether the reappearance of vinculin in adhesion 
plaques by 60 min after PDGF exposure results from vinculin 
accumulation to previously existing adhesion plaques is not 
FIGURE 1 Effect of PDGF treatment on vinculin (A-C) and actin (D-F) distribution in BALB/c-3T3 cells. In untreated cells, vinculin 
staining is found predominantly in adhesion plaques (arrowheads in A) near sites of cell-cell contact or cell-substrate interaction 
and in a diffuse distribution throughout the cytoplasm. Actin is disposed as stress fibers which course throughout the cell or are 
concentrated around the cell periphery (D). Within 2.5-5 min after exposure of cells to 50 ng/ml of PDGF, vinculin staining has 
disappeared from adhesion plaques and assumes a punctate perinuclear distribution (B). The distribution of actin is unchanged 
at this time (E). By 60 min after continual exposure of cells to 50 ng/ml of PDGF, vinculin has reappeared in adhesion plaques 
(arrowheads in C), while stress fiber staining is essentially absent (F). n, Nucleus. Bars, 10 #M. 
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FIGURE 2 Effect of PDGF treatment (12 ng/ml for 20 min at 37°C) on vinculin (A and B), talin (C and D), vimentin (E and F), and 
microtubule (G and H) distribution in BALB/c~3T3 cells. Vinculin is concentrated in adhesion plaques at sites of cell-cell or cell- 
substratum contact in untreated cells (arrowheads in A). After exposure to PDGF, vinculin staining in adhesion plaques is lost 
(arrowheads in B) and assumes a punctate distribution within the cytoplasm. Talin, another adhesion plaque protein (C), has an 
identical distribution to that of vinculin, being localized in adhesion plaques. Unlike vinculin, PDGF treatment has no effect on 
talin distribution or staining (D; cell edge delineated by arrowhead). Intermediate filaments (vimentin) display an interlacing 
network of fibers (E) which are also unaffected by PDGF treatment (F). Microtubules are disposed as a radial network of fibers 
originating from a perinuclear organizing center (arrowhead in G) and this distribution is unaltered by PDGF treatment (H). n, 
Nucleus. Bars, 10 #M. 
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known. PDGF addition did not alter the organization of 
intermediate filaments (vimentin [Fig. 2, E and F]) or micro- 
tubules (tubulin [Fig. 2, G and/at]). No change in cell shape 
was noted during these experiments, suggesting that the cells 
remained attached to the substrate for the duration of PDGF 
exposure. Exposure of BALB/c-3T3 cells to EGF (10 ng/ml), 
insulin (10 ~M), SmC (30 ng/ml), 5% PPP, or 0. 1% PPP had 
no effect on vinculin or actin distribution in BALB/c-3T3 
cells. 
Fig. 3 illustrates the time- and dose-dependent disappear- 
ance of vinculin staining from adhesion plaque structures or 
actin stress fiber staining in cells after exposure of cells to 
varying doses of PDGF. At very high doses (50 ng/ml), 
adhesion plaque staining disappears (up to 95%) within 2.5 
min after PDGF addition (Fig. 3A), while stress fiber staining 
does not disappear until 5-10 min after exposure to PDGF 
(Fig. 3B). Progressively lower doses of PDGF (25 or 12 ng/ 
ml) bring about a somewhat slower but quantitatively similar 
disappearance in vinculin staining; however, the kinetics of 
the disruption of actin stress fibers appears independent of 
dose at these concentrations. Cells exposed to 6.25 ng/ml 
PDGF display only a partial disappearance of vinculin stain- 
ing from adhesion plaques (~50% at 15 rain after treatment), 
whereas no effect was found on stress fibers at this concentra- 
tion. This figure also illustrates that between 30 and 60 rain 
after exposure of cells to PDGF, vinculin staining reappears 
in adhesion plaques (Fig. 3.4), while stress fibers have not 
recovered even by 90 min after PDGF addition (Fig. 3B). 
The findings that PDGF treatment results in the rapid disap- 
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pearance of vinculin from the adhesion plaques before the 
disappearance of actin-containing stress fibers suggests that 
the primary effect of PDGF treatment is to cause vinculin 
disruption from adhesion plaques. The subsequent disruption 
of actin-containing stress fibers may be secondary to the 
disruption of vinculin in the adhesion plaques since many 
morphological and biochemical studies have indicated that 
actin-containing stress fibers are tethered at adhesion plaques 
or focal contacts through an interaction with vinculin (21). 
Specif ic i ty o f  G r o w t h  Factor M o d u l a t i o n  o f  
Vincul in D is t r ibu t ion  
When BALB/c-3T3 cells are rendered competent by brief 
exposure to PDGF, the subsequent addition of EGF and 
insulin-like growth factors (or PPP) induces progression 
through the G0/GI phases of the cell cycle and entry into S 
phase. In addition to PDGF, other agents, including FGF, 
calcium phosphate (Ca3[PO4]), and a macrophage-derived 
growth factor have been shown to be able to induce this 
competent state in BALB/c-3T3 cells. Table I illustrates the 
effect some of these compounds and various other growth 
factors or hormones on the distribution of vinculin and actin 
staining shortly after addition to density-arrested BALB/c- 
3T3 cells. Both FGF and CaCb disrupted adhesion plaque 
and stress fiber staining, though to a lesser extent than did 
PDGF (Table I). TGF at higher concentrations ( l -  10 ng/ml) 
also caused a disappearance of vinculin and actin staining in 
cells. At the concentrations of PDGF used in our studies, the 
FIGURE 3 Time- and dose-dependent effect 
of PDGF treatment on vinculin adhesion 
plaque and actin stress fiber staining in 
BALB/c-3T3 cells exposed to PDGF. At high 
PDGF concentrations, vinculin staining dis- 
appears within 2.5 min after PDGF addition 
(top), while actin-containing stress fibers do 
not undergo disruption until 10 min after ex- 
posure of cells to PDGF (bottom). Whereas 
the disappearance of vinculin staining is de- 
pendent on the dose of PDGF (top), stress 
fiber break-down appears relatively dose-in- 
dependent (at the higher PDGF concentra- 
tions) (bottom). By 60 min after PDGF addi- 
tion, vinculin staining has reappeared in adhe- 
sion plaques (top), while most cells are still 
devoid of actin-containing stress fibers (bot- 
tom). 
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level of contaminating TGF was shown to be negligible by 
radio receptor assay (personal communication, Dr. Hal 
Moses), and therefore could not be responsible for PDGF's 
effect on vinculin and actin distribution. Choleragen (cholera 
toxin [C.T.]), which has been shown to enhance DNA syn- 
thesis by potentiating the action of PDGF (32), caused a very 
efficient and rapid disruption of vinculin staining in adhesion 
plaques and stress fiber staining in BALB/c-3T3 cells. In 
contrast to PDGF or other BALB/c-3T3 competence factors, 
exposure of cells to EGF (0.1-30 ng/ml), PPP (5% or 0.1%), 
SmC (30 ng/ml), or insulin (10 ~M) had no effect on vinculin 
adhesion plaque or actin stress fiber staining in the BALB/c- 
3T3 cells. None of the agents listed in Table I altered the 
staining patterns of any other cytoskeletal structures during 
these brief incubation periods. 
Effect of Addition of EGF, PPP, or Insulin on 
Vinculin and Actin Distribution after Brief 
Exposure to PDGF 
Previous work has shown that subsequent to transient 
exposure to PDGF, ceils could be induced to enter the S 
TABLE I 
Percent Disruption of Vinculin and Actin Staining at 15 Min 
after Ligand Addition 
Ligand Dose 
% cells % cells 
without vin- without 
culin stain- stress 
ing in adhe- fiber 
sion plaques staining 
None {control) - -  <3 <5 
PDGF 6.5 ng]ml 18 7 
12 ng/ml 83 93 
25 ng/ml 93 88 
TGF 0.1 ng/ml 65 50 
1 ng/ml 67 54 
I0 ng/ml 30 50 
FGF 25 ng/ml 15 12 
50 ng/ml 27 23 
100 ng/ml 29 30 
C.T. 1 ng/ml 68 88 
100 ng/ml 90 92 
1,000 ng/ml 88 90 
CaCI2 15 mM 35 50 
EGF 0.1 ng/ml <5 <5 
I ng/ml <5 <5 
30 ng/ml <5 <5 
PPP 5% <5 <5 
0.1% <5 <5 
SmC 30 ng/ml <5 <5 
Insulin 10 ~,M <5 <5 
5-d cultures of BALB/c-3T3 cells grown on coverslips and maintained in DME 
containing 10% calf serum were treated with DME containing PDGF, TGF, 
FGI-, EGF, C.T., CaCI2, PPP, SmC, or insulin at the concentrations indicated 
for 15 min at 37°C, and fixed and processed for the immunofluorescent 
demonstration of vinculin and actin as described in the Materials and Meth- 
ods. 150 200 cells per coverslip were counted and scored for the presence 
or absence of adhesion plaque or stress fiber staining. The percentage of 
cells without staining for adhesion plaques or stress fibers is indicated. 
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phase of the cell cycle by plasma (39). Further investigations 
have demonstrated that the requirement for plasma could be 
replaced by EGF, and either insulin or SmC (35). In addition, 
it was found that the competent state induced by PDGF 
decayed with a half life of 18 h; addition of plasma for up to 
13-18 h after removal of PDGF still resulted in the entry of 
cells into S phase (50). We investigated whether addition of 
EGF, insulin, or PPP after removal of PDGF led to any 
rearrangement in vinculin or actin distributions in BALB/c- 
3T3 cells. The results of this study are presented in Fig. 4. As 
demonstrated earlier, vinculin staining within adhesion 
plaques reappears within 60 min after PDGF exposure, while 
actin stress fibers have not reformed by this time (Fig. 1, b 
and c, and Fig. 4 a). When PDGF was removed from the cells 
at this time and EGF was added, vinculin staining within 
adhesion plaques disappeared within 15 min (Fig. 4 b). This 
response was found to occur up to 8 h after removal of PDGF 
(Fig. 4 c), and could also be brought about by the addition of 
5% PPP after the removal of PDGF. These treatments had 
no effect on talin staining or the distribution (staining) of 
other cytoskeletal structures. Addition of 10 ~M insulin (Fig. 
4f )  or 0.1% PPP (Fig. 4e) after the removal of PDGF had no 
effect on the distribution of vinculin staining in these cells. 
These results suggest that the alterations observed in the 
vinculin component of adhesion plaques, and stress fiber 
structure, are related to the induction of competence by 
PDGF and the further signaling of cells to enter the S phase 
by PPP or EGF. 
To further test the hypothesis that vinculin disappearance 
from adhesion plaques is correlated with the initiation of 
growth of quiescent cells by PDGF, we measured the amount 
of DNA synthesis ([3H]thymidine uptake) as a function of 
PDGF concentration (after further treatment of cells with 5 % 
PPP). The percentage of cells which took up [gH]thymidine 
was correlated with the percentage of cells lacking adhesion 
plaque vinculin staining as a function of PDGF concentration. 
These data are plotted and shown in Fig. 5. As can be seen, 
the actual percentage of cells without adhesion plaque vin- 
culin staining is almost identical to the percentage of the cells 
which were labeled with [3H]thymidine. The close correlation 
between the disappearance of vinculin from adhesion plaques 
and cell growth (see inset, Fig. 5) suggests that an early event 
in the initiation of cell growth by PDGF in quiescent BALB/ 
c-3T3 cells may involve the reversible disruption of vinculin 
from adhesion plaques or focal contacts. 
Synergy between PDGF and EGF or PPP 
PDGF has been shown to sensitize BALB/c-3T3 cells to 
EGF and reduce the concentration of EGF required for 
mitogenic stimulation of 10Tt/2 cells (39). This effect of PDGF 
may occur through reactions that affect the EGF receptor, 
since PDGF treatment alters EGF receptor number (56). We 
wondered if this synergy between PDGF and EGF (the in- 
creased sensitivity of cells to EGF after exposure to PDGF) 
was also reflected in changes in the distribution of vinculin 
and actin staining in cells. We approached this question by 
first treating cells with a high (12 ng/ml) or low dose (3.25 
ng/ml) of PDGF for 60 min followed by treatment with EGF 
( 10 ng/ml), insulin (10 uM), or PPP (5% or 0.1%). The results 
of these experiments are shown in Table II. Treatment of cells 
with low doses of PDGF (3.25 ng/ml) did not result in loss of 
vinculin staining from adhesion plaques; exposure of cells to 
high doses of PDGF (12 ng/ml) results in the transient dis- 
appearance of vinculin staining in adhesion plaques (see Fig. 
FIGURE 4 Vinculin staining in cells treated with 12 ng/ml PDGF for 60 rain (A) followed by 10 ng/ml EGF (B and C), 5% PPP (D), 
0.1% PPP (E), or 10 #M insulin for 15 rain at 37°C. Vinculin staining reappears in adhesion plaques within 60 rain after exposure 
to PDGF (A); subsequent removal of PDGF followed by addition of 10 ng/ml EGF results in the disappearance of vinculin staining 
within 15 min (B). Addition of EGF up to 8 h after removal of PDGF continues to result in the abolishment of vinculin staining in 
adhesion plaques within 15 rain of EGF addition (C). PDGF treatment followed by addition of 5% PPP also abolished vinculin 
adhesion plaque staining (D), while 0.1% PPP (E) or 10/~M insulin (F) following PDGF treatment had no effect on vinculin staining 
(compare arrowheads in A and F). n, Nucleus. Bars, 10/~M. 
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FIGURE 5 DNA synthesis (0) and disappearance of vinculin stain- 
ing from adhesion plaques (O) as a function of PDGF concentration. 
The percentage of cells which contain labeled nuclei closely par- 
allels the percentage of cells without vinculin adhesion plaque 
staining at all doses of PDGF (see inset). 
1), which had returned by 60 min after PDGF addition (Table 
II). Addition of EGF to cells after a 60-rain exposure to low 
doses of PDGF results in the rapid disappearance of vinculin 
adhesion plaque staining and actin stress fiber staining. Sim- 
ilar treatment with 5% PPP yielded the same results, while 
treatment of cells with EGF alone or with 0.1% PPP or 10 
uM insulin following PDGF had no effect. Thus, PDGF and 
EGF seem to act in a synergistic manner with respect to 
alterations in the cellular distribution of vinculin and actin. 
DISCUSSION 
The biochemical mechanisms which regulate cell growth are 
unknown. The use of serum-derived growth factors in con- 
junction with tissue culture cells has allowed investigators to 
study biochemical changes associated with growth. These 
approaches have led to the discovery that different phases of 
the cell cycle can be regulated by different serum-derived 
growth factors (35, 36, 39). Specifically, PDGF stimulates 
arrested (quiescent) BALB/c-3T3 cells, in a concentration- 
and temperature-dependent manner, to leave Go and enter 
the cell cycle (41). The traverse of Go/G, and entry into S 
phase can be facilitated by EGF and SmC (40, 42). The 
induction of competence and growth initiation by PDGF 
apparently involves increases in gene expression as illustrated 
by the induction of unique mRNA and proteins (52). The 
mechanism whereby PDGF alters gene expression by binding 
specific receptors is unknown and remains an important focus 
of investigation. 
The findings that only brief exposure of cells to PDGF is 
necessary to render cells sensitive to EGF and SmC (5 l) 
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TABLE II 
Vinculin and Actin Staining 75 Min after Sequential Additions 
of Ligands 
Primary ligand Secondary ligand 
% cells 
without 
vinculin % cells 
staining without 




PDGF (3.25 ng/ml) - -  11 10 
PDGF (12 ng/ml) 23 85 
EGF (10 ng]ml) - -  <5 <5 
PDGF (12 ng/ml) EGF (10 ng/ml) 68 74 
PDGF (3.25 ng/ml) EGF (10 ng/ml) 72 71 
PDGF (3.25 ng]ml) 5.0% PPP 68 35 
PDG F (3.25 ng]ml) 0.1% PPP 13 11 
PDGF (3.25 ng/ml) Insulin (10 ttM) 21 18 
5-d old BALB/c-3T3 cells grown in DME were exposed to the same medium 
containing the primary ligand at the concentrations indicated in the table for 
60 min at 37°C. The medium containing the primary ligand was removed 
and replaced by DME containing the secondary ligand at the concentrations 
indicated for 15 rain at 37°C. Cells were then fixed and processed for the 
immunofluorescent demonstration of vinculin and actin as described in the 
Materials and Methods section. 150-200 cells were scored for the presence 
or absence of adhesion plaque or stress fiber staining. The percentage of 
ce(Is without adhesion plaque or stress fiber staining is indicated. 
suggest that rapid alterations in cellular structure or function 
which occur early after PDGF addition to cells may be 
responsible for PDGF-induced competence. We have found 
that exposure of BALB/c-3T3 cells to PDGF leads to rapid 
and reversible, time- and dose-dependent alterations in vin- 
culin and actin distribution. Within 2.5 rain after PDGF 
exposure, vinculin staining disappears from adhesion plaques 
(Fig. l) while actin staining, in the form of stress fibers, 
becomes disrupted between 5 and l0 min after PDGF addi- 
tion. Adhesion plaques (focal contacts) are regions where actin 
microfilaments terminate in cells such as cultured fibroblasts 
and where the plasma membrane comes close to the under- 
lying substrate. Various actin-binding proteins have been 
localized to this region of the plasma membrane (l, 7, 20, 
21), and include a-actinin, fimbrin, talin, and vinculin. Pre- 
vious findings using immunocytochemistry indicate that actin 
microfilaments terminate in vinculin contained in adhesion 
plaques or focal contacts (21). The PDGF-induced disap- 
pearance of vinculin from adhesion plaques is reversible in 
that, by 60 min after treatment of cells with PDGF, vinculin 
staining has reappeared in adhesion plaques, whereas stress 
fibers have not reformed by this time. Stress fiber staining 
does eventually reappear within 120-180 min after PDGF 
addition (3) (also Herman, B., and W. J. Hedger, unpublished 
data). The slower kinetics of actin stress fiber disruption, 
coupled with the findings that stabilization of actin microfi- 
laments with phalloidin (3) does not prevent PDGF-induced 
competence, suggests that microfilament breakdown is not 
required for induction of competence but is probably second- 
ary to the disruption of vinculin from adhesion plaques. The 
findings that no microfilament disruption occurs at concen- 
trations of PDGF which result in disappearance of -50% of 
the detectable vinculin staining (see Fig. 3), and that a syner- 
gistic effect of PDGF and EGF with respect to vinculin 
disappearance from adhesion plaques and cell growth can be 
demonstrated at these low doses of PDGF, strengthens the 
argument that micro filament breakdown is not important in 
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the induction of competence. 
That the effect of PDGF is specific for vinculin is shown 
by the findings that neither talin (another adhesion plaque 
protein), vimentin (intermediate filament), nor tubulin (mi- 
crotubule) staining is affected by PDGF treatment (see Fig. 
2). This suggests that focal contacts or adhesion plaques 
remain intact in cells after exposure to PDGF, and that 
vinculin is specifically removed from these structures after 
PDGF addition. These results are in agreement with our 
observations that no change in cell shape occurs during the 
alterations in vinculin distribution after exposure of cells to 
PDGF. Previous work from other laboratories (33) has shown 
that PDGF treatment (1.3 nM) of serum-starved glial cells 
results in a large increase in membrane ruffling activity and 
extension of lamellapodia. These changes, which occur within 
1 to 60 min of PDGF addition, are also associated with 
translocation of membrane from the cell periphery to the cell 
center and an increased shuttling of intracellular particles. 
These alterations in membrane activity were associated with 
a rearrangement of actin microfilaments yielding a substrate 
set of stress fibers as well as a high concentration of actin 
filaments in the membrane ruffles. PDGF treatment did not 
cause the disappearance of actin staining in these cells as it 
does in BALB/c-3T3 (see Fig. 1); it is not known whether 
similar changes in membrane ruffling activity occur shortly 
after PDGF treatment of BALB/c-3T3 cells and if so whether 
the alterations we observe in vinculin distribution may be 
related to this phenomenon. It is interesting to note that 
similar changes in ruffling activity, increases in micropino- 
cytic activity, and microfilament organization have been re- 
ported in A431 cells shortly after treatment with EGF (9). 
Thus an early effect of growth factors in general may be to 
enhance membrane turnover activity and cause alterations in 
intraceUular actin distribution. It is not known, however, 
whether these alterations in membrane activities and micro- 
filament distributions are related to cell growth and whether 
concomitant disruption of vinculin from adhesion plaques 
occurs during these processes. 
The hypothesis that alterations in vinculin may be related 
to competence induction in BALB/c-3T3 cells is strengthened 
by the findings that other agents which have been shown to 
induce competence in BALB/c-3T3 cells (FGF, choleragen, 
and Ca2+), also cause the disappearance of vinculin from 
adhesion plaques. Other growth factors (e.g., EGF or SmC) 
and insulin had no effect on vinculin staining in these cells, 
suggesting that the disruption of vinculin staining in adhesion 
plaques is not a general biological effect of growth factor or 
hormone binding. How PDGF might induce competence in 
BALB/c-3T3 cells is not known. The findings that (a) chol- 
eragen potentiates the effects of suboptimal PDGF concentra- 
tions (56), (b) IBMX enhances the action of choleragen (32), 
and (c) the differential sensitivity of various cell lines to PDGF 
can be related to their intracellular cAMP concentration (37), 
suggest that PDGF can sensitize cells to the action of EGF 
possibly through a cAMP-mediated mechanism. It is interest- 
ing to note that PDGF has also been shown to decrease EGF 
binding to BALB/c-3T3 cells (56) which is augmented by 
cholera toxin treatment. Whether the decrease in the amount 
of EGF bound is due to EGF receptor internalization or due 
to masking of plasma membrane receptors is not known; this 
decrease suggests, however, that PDGF may make cells com- 
petent by causing down regulation of the EGF receptor which 
is necessary for mitogenesis. Alternatively, the action of 
PDGF and EGF may be via two different pathways necessary 
for the entry of cells into S phase. 
Further support for a role of  vinculin in the interaction of 
PDGF and EGF in cell cycle progression comes from our 
findings that vinculin staining disappears from adhesion 
plaques in cells treated with EGF after exposure to low doses 
of  PDGF, which by itself does not disrupt vinculin adhesion 
plaque staining (see Table II). This strengthens the interpre- 
tation that PDGF can sensitize cells to the action of other 
specific growth factors; the observation that this vinculin 
disruption from adhesion plaques can still occur even up to 
8 h after PDGF removal (Fig. 4) is consistent with the prop- 
erties of  PDGF-induced competence. Lastly, the nearly equiv- 
alent percentage of cells which demonstrate absence of  vin- 
culin adhesion plaque staining and [3H]thymidine-labeled 
nuclei at various concentrations of PDGF suggests that vin- 
culin disruption is important for the induction of competence 
and entry of cells into the cell cycle. 
Binding of PDGF to purified plasma membranes results in 
the rapid stimulation of a membrane-associated protein ki- 
nase, which phosphorylates two major polypeptides (molec- 
ular weights of  185,000 and 130,000) and several minor 
components of  the membrane fraction (17). The 185,000- 
mol-wt protein is thought to be the PDGF receptor, whereas 
the identity of  the 130,000-mol-wt protein is not known 
(although this is the molecular weight of  vinculin as deter- 
mined by gel electrophoresis). Part of  this phosphorylation is 
on the tyrosine residues in these proteins (10, 17, 26, 27, 48). 
In vivo, PDGF addition to Swiss 3T3 cells has been shown to 
phosphorylate two 45-kD, two 43-kD, and one 42-kD proteins 
at tyrosine residues (10). Similar changes were noted in these 
cells when they were exposed to EGF, which suggests that 
phosphorylation of cellular substrates at tyrosine residues may 
be a common mechanism of action of the two growth factors. 
The lack of detectability of  higher molecular weight phospho- 
rylated proteins (as was found in isolated membrane fractions) 
may be due to the biochemical fractionation procedures which 
involve the use of fluoride and EDTA, which stimulate phos- 
pho-tyrosine protein phosphatase in whole cells and may 
rapidly dephosphorylate certain proteins (16). 
The fact that the PDGF and EGF receptors contain a 
tyrosine kinase activity (8) which is similar to the tyrosine 
kinase activity of  oncogene protein products (23, 26, 52) 
suggests that the action of the receptor and oncogene proteins 
may be similar with respect to growth-promoting activity. It 
has recently been found that the s r c  oncogene protein product 
has been localized to adhesion plaques (43, 50), and the 
alterations in actin distribution observed after oncogene trans- 
formation (11) are very similar to the early changes in actin 
distribution we observe after exposure of BALB/c-3T3 cells. 
Additional work demonstrates that the tyrosine kinase s r c  
oncogene protein phosphorylates vinculin (28, 48). The recent 
findings which demonstrate that vinculin is a substrate for 
protein kinase c (55), that phorbol esters have been shown to 
cause vinculin phosphorylation (54) and the specific redistri- 
bution of vinculin and actin (47), and that PDGF addition 
results in rapid increases in intracellular C a  2+ (34), suggest 
that phosphorylation of vinculin may regulate its activity with 
respect to cell growth. The very recent findings that the simian 
sarcoma virus oncogene (v-sis) codes for the ~ chain of PDGF 
(12, 14, 15, 29) suggests that studies of  the biochemical 
regulation of growth by PDGF may be important in helping 
elucidate the mechanisms of oncogenesis. 
Received for publication 28 September 1984, and in revised form 11 
December 1984. 
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